Submissions for variant NM_000329.3(RPE65):c.370C>T (p.Arg124Ter)

gnomAD frequency: 0.00013  dbSNP: rs61752877

Total submissions: 12

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
ClinGen Leber Congenital Amaurosis/early Onset Retinal Dystrophy Variant Curation Expert Panel, ClinGen	RCV003764794	SCV004697429	pathogenic	RPE65-related recessive retinopathy	2024-02-20	reviewed by expert panel	curation	NM_000329.3(RPE65):c.370C>T (p.Arg124Ter) is a nonsense variant that introduces a premature stop codon into exon 5 of 14, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is present in gnomAD v.2.1.1 at a GrpMax allele frequency of 0.00002191, with 9 alleles / 24480 total alleles in the African/African-American population, which is lower than the ClinGen LCA / eoRD VCEP PM2_Supporting threshold of <0.0002 (PM2_Supporting). This variant has been reported in at least 1 proband with early-onset severe retinal dystrophy who was homozygous for the variant (0.5 pts, PMID: 35129589, PM3_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA / eoRD VCEP: PVS1, PM2_Supporting, PM3_Supporting. (VCEP specifications version 1.0.0; date of approval 09/21/2023).
Invitae	RCV000538669	SCV000644182	pathogenic	Leber congenital amaurosis 2; Retinitis pigmentosa 20	2024-01-07	criteria provided, single submitter	clinical testing	This sequence change creates a premature translational stop signal (p.Arg124*) in the RPE65 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPE65 are known to be pathogenic (PMID: 9326941, 9501220, 9843205, 18632300). This variant is present in population databases (rs61752877, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with Leber congenital amaurosis (PMID: 9501220, 19854499, 20683928). ClinVar contains an entry for this variant (Variation ID: 98866). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Mendelics	RCV000986332	SCV001135305	pathogenic	Leber congenital amaurosis 2	2019-05-28	criteria provided, single submitter	clinical testing
GeneDx	RCV000085195	SCV001795678	pathogenic	not provided	2019-08-20	criteria provided, single submitter	clinical testing	Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 32865313, 33576794, 30996589, 31630094, 31736247, 30608580, 28559085, 30268864, 29332120, 9501220, 19854499, 11095629, 25257057, 20683928, 28005406, 15691574, 28945494, 28237426, 20079931, 25525159)
Fulgent Genetics, Fulgent Genetics	RCV002490740	SCV002797742	pathogenic	Leber congenital amaurosis 2; Retinitis pigmentosa 20; Retinitis pigmentosa 87 with choroidal involvement	2022-03-30	criteria provided, single submitter	clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp	RCV001275332	SCV003800725	pathogenic	Leber congenital amaurosis	2023-01-19	criteria provided, single submitter	clinical testing	Variant summary: RPE65 c.370C>T (p.Arg124X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been reported in HGMD in association with Leber congenital amaurosis and Retinal degeneration. The variant allele was found at a frequency of 3.6e-05 in 250738 control chromosomes. c.370C>T has been reported in the literature in multiple individuals affected with Leber Congenital Amaurosis and inherited retinal dystrophies (examples: Galvin_2005, Zhong_2019, Zenteno_2019, Lopez-Rodriguez_2021, Testa_2022). These data indicate that the variant is very likely to be associated with disease. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Ambry Genetics	RCV003242981	SCV003942962	pathogenic	Inborn genetic diseases	2023-06-12	criteria provided, single submitter	clinical testing	The c.370C>T (p.R124*) alteration, located in coding exon 5 of the RPE65 gene, consists of a C to T substitution at nucleotide position 370. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 124. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the T allele has an overall frequency of 0.006% (16/282008) total alleles studied. The highest observed frequency was 0.037% (9/24480) of African alleles. This variant has been reported in compound heterozygous state in multiple individuals with RPE65-related retinopathies (Kumaran, 2018; Chung, 2019; Maltese, 2022). This variant has also been reported as a homozygous finding in an child with Leber congenital amaurosis whose parents were consanguineous (Zhong, 2019). Based on the available evidence, this alteration is classified as pathogenic.
Baylor Genetics	RCV000986332	SCV004209207	pathogenic	Leber congenital amaurosis 2	2023-10-30	criteria provided, single submitter	clinical testing
Dept Of Ophthalmology, Nagoya University	RCV003888467	SCV004705508	pathogenic	Retinal dystrophy	2023-10-01	criteria provided, single submitter	research
Retina International	RCV000085195	SCV000117332	not provided	not provided		no assertion provided	not provided
Laboratory of Genetics in Ophthalmology, Institut Imagine	RCV000986332	SCV001425582	pathogenic	Leber congenital amaurosis 2		no assertion criteria provided	research
Natera, Inc.	RCV001275332	SCV001460406	pathogenic	Leber congenital amaurosis	2020-09-16	no assertion criteria provided	clinical testing